%0 Journal Article
%T Prospective study: expression levels of microRNA-7-3p and its target STAT3 in head and neck cancer.
%A Anees FF
%A Preethi KA
%A Selvakumar SC
%A Murthykumar K
%A Ganapathy D
%A Sekar D
%J Minerva Dent Oral Sci
%V 72
%N 6
%D 2023 Dec 16
%M 37326506
暂无%R 10.23736/S2724-6329.23.04824-6
%X <B>BACKGROUND: </B>Head and neck cancer (HNC) is the seventh most prevalent type of cancer in the globe, and it encompasses a wide range of tumors that affect the oral, facial and neck region. Despite breakthroughs in treatment strategies, patients survival has not increased substantially in the last few decades. Therefore, there is need for quick and reliable biomarkers and therapeutic targets for the treatment of HNC. Interestingly, microRNAs (miRNAs) are a small non-coding RNAs (ncRNAs) that have a role in the post-transcriptional regulation of gene expression. Thus, the aim of the study is to evaluate the role of miR-7-3p in the HNC and normal tissues.<BR><B>METHODS: </B>A total of 25 HNC and normal tissues were collected from the Department of Oral and Maxillofacial Surgery, Saveetha Dental College and Hospitals. Bioinformatic tool (TargetScan) was used to predict the target for miR-7-3p. The tissue samples were processed for Hematoxylin and Eosin staining and following that total RNA was extracted and analyzed for expression studies using RT-qPCR.<BR><B>RESULTS: </B>The bioinformatic analysis of the current study have revealed that STAT3 is a direct target for miR-7-3p. The histopathological examination showed damaged epithelial cells and keratin pool formation was observed in HNC tissue. Our results have also revealed that the miR-7-3p levels were significantly reduced and STAT3 levels were significantly higher in the HNC tissues when compared to the normal tissues.<BR><B>CONCLUSIONS: </B>MiR-7-3p can be used as a prognostic, diagnostic biomarker and therapeutic target for the treatment of HNC.